It's important to note that itch is the most burdensome symptom of seborrheic dermatitis," says Dr. Woolerry-Lloyd. She also ...

From a clinical perspective, the best evidence that seborrheic dermatitis is driven by inflammation comes from the pivotal phase 3 trial of patients aged 9 years or older with seborrheic ...

The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis of the scalp and ...

New York — Seborrheic dermatitis (SD) is a common and shared ... was effective for SD in a vehicle-controlled phase 3 trial published in 2023. Kwatra characterized the adverse event profile ...

BOSTON--(BUSINESS WIRE)--DermBiont, a clinical ... trial with a topical formulation of investigational drug SM-020, a specific and potent AKT inhibitor applied by patients at home to their ...

Odell Beckham Jr. first noticed flakes throughout his iconic beard and hairline in his 20s; today, for the first time he is sharing his experience with ZORYVE® (roflumilast) topical foam, 0.3% ...

for plaque psoriasis in a cream formulation and for seborrheic dermatitis (scalp eczema) in a foam formulation. Zoryve May Improve Itch as Soon as 24 Hours After Use In phase 3 clinical trials ...

Psoriasis has many imitators, but one that comes very close is seborrheic dermatitis. That’s because both conditions can cause red, scaly, inflamed patches on your skin. To tell the two apart ...

in its first clinical trial for BBT001, a novel, multi-targeting, half-life extended bispecific antibody, which is being developed initially as a treatment for atopic dermatitis (AD). "The early ...